Medical Device Specialty Stocks Beat Q1 Revenue Estimates by 5.2%, Inspire Medical (INSP) Mixed

Medical devices and supplies - specialty companies posted a strong first quarter of 2026, with the seven firms tracked by analysts surpassing consensus revenue forecasts by an average of 5.2%, according to results released as of May 29. The sector’s broad top-line beat underscores resilient demand for implantable and surgical technologies despite ongoing pricing pressures from insurers and healthcare systems. Inspire Medical Systems (NYSE:INSP), which makes an implantable sleep apnea device, reported Q1 revenue of $204.6 million, up 1.6% year-on-year and edging estimates by 1.9%. However, the company’s full-year EPS and revenue guidance missed analysts’ expectations, and the stock slipped 0.9% since the report to $43.87. Among peers, STAAR Surgical (STAA) posted the fastest growth—revenue soared 120% to $93.5 million, beating estimates by 20.8%—while Integer Holdings (ITGR) delivered flat sales and missed full-year guidance. Globus Medical (GMED) raised its full-year EPS outlook, but Enovis (ENOV) issued the weakest guidance update, and its shares fell 7.2%. Shares of the group have held broadly flat since earnings, reflecting a market that had largely priced in the results.